4//SEC Filing
Kunkel Lori Anne 4
Accession 0001536368-25-000006
CIK 0001796280other
Filed
Dec 8, 7:00 PM ET
Accepted
Dec 9, 5:35 PM ET
Size
7.0 KB
Accession
0001536368-25-000006
Insider Transaction Report
Form 4
Kunkel Lori Anne
Director
Transactions
- Exercise/Conversion
Common Stock
2025-12-08$7.90/sh+10,000$79,000→ 84,200 total - Exercise/Conversion
Stock Option (right to buy)
2025-12-08−10,000→ 15,600 totalExercise: $7.90Exp: 2034-06-11→ Common Stock (10,000 underlying)
Footnotes (1)
- [F1]One hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) June 12, 2025 or (ii) the business day prior to the next annual meeting of the Issuer's stockholders that occurs following the date of grant.
Documents
Issuer
Oric Pharmaceuticals, Inc.
CIK 0001796280
Entity typeother
Related Parties
1- filerCIK 0001536368
Filing Metadata
- Form type
- 4
- Filed
- Dec 8, 7:00 PM ET
- Accepted
- Dec 9, 5:35 PM ET
- Size
- 7.0 KB